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Thy-1 is a 25–37 kDa glycosylphosphatidylinositol (GPI)-anchored protein involved in T cell activation, neurite outgrowth, apoptosis, tumor
suppression, wound healing, and fibrosis. To mediate these diverse effects, Thy-1 participates in multiple signaling cascades. In this review, we
discuss Thy-1 signaling primarily in non-immunologic cell types, including neurons, mesangial cells, ovarian cancer cells, nasopharyngeal
carcinoma cells, endothelial cells, and fibroblasts. We review the current literature regarding Thy-1 signaling via integrins, protein tyrosine
kinases, and cytokines and growth factors; and the roles of these signaling pathways in cellular adhesion, apoptosis, cell proliferation, and cell
adhesion and migration. We also discuss the role of Thy-1 localization to lipid rafts, and of the GPI anchor in Thy-1 signaling. Ongoing research
on the mechanisms of Thy-1 signaling will add to our understanding of the diverse physiologic and pathologic processes in which Thy-1 plays a
role.
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Thy-1 is a 25–37 kDa GPI-anchored cell surface protein ex-
pressed in various cell types, including fibroblasts, ovarian
cancer cells, endothelial cells, neurons, and hematopoietic cells
[1,2]. Thy-1 expression is developmentally regulated in neurons
and ovarian follicular cells [3–6]. For example, it is expressed on
mature neurons, but not on growing neurons [7]. The expression
of Thy-1 can be regulated transcriptionally in nasopharyngealAbbreviations:COX, cyclooxygenase; FAK, focal adhesion kinase; Gadd 45
γ, DNA-damage-inducible protein 45 gamma; GAP, GTPase activating protein;
GPI, glycosylphosphatidylinositol; LAT, linker for activation of T cells; MAPK,
mitogen-activated protein kinase; NCAM, neural cell adhesion molecule; NGFI-
B, nerve growth factor induced protein I-B; NPC, nasopharyngeal carcinoma;
PDGF, platelet-derived growth factor; PG, prostaglandin; PI 3-kinase,
phosphatidylinositol 3-kinase; PKC, protein kinase C; PTK, protein tyrosine
kinase; SFK, Src family kinase; SMA, smooth muscle actin; STAT3, signal
transducer and activator of transcription 3; TGF, transforming growth factor;
TNF, tumor necrosis factor; TUNEL, TdT-mediated dUTP nick-end labeling
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doi:10.1016/j.bbamcr.2006.08.008carcinoma and T cell lymphoma, potentially by promoter hyper-
methylation [8,9], or post-transcriptionally in neurons due to an
unidentified trans-acting suppressor, or by shedding [10–14].
Based on studies using Thy-1 knockout mice, Thy-1 appears
to be important for certain neurologic and immunologic
functions, and for tissue remodeling in response to injury.
Thy-1 knockout mice are viable, with no apparent major
abnormalities. However, they display inhibition of hippocampal
long-term potentiation in the dentate gyrus but not in the CA1
region [15]. Although these mice have no impairments in spatial
learning assessed by a water maze, they fail to base their food
choices on socially-transmitted cues, indicating that specific
regions of the hippocampus are involved in different types of
learning and memory [15,16]. Interestingly, anti-Thy-1 anti-
body administration abolishes both immediate and long-term
memory in 2-day-old chicks [17]. Thy-1 knockout mice also
have impaired cutaneous immune responses and abnormal
retinal development [18,19]. Our laboratory has studied the
susceptibility of Thy-1 knockout mice to pulmonary fibrosis.
Following intratracheal bleomycin (see Section 5, below),Thy-1
knockout mice develop more severe fibrosis, as evidenced by
Table 2
Summary of Thy-1 signaling via tyrosine kinases
Cell type Signaling pathway Effect
Mesangial
cells
Fyn, lyn Apoptosis induction
Mesangial
cells
Smad1, STAT3 Cell proliferation
Pulmonary
fibroblasts
↓SFK, ↓p190RhoGAP,
RhoA activation
Focal adhesion and
stress fiber formation,
Decreased migration
Neurons Fyn, lyn, Gαi,
α- and β-tubulin,
reggie-1 and -2
Unknown
T cells Calcineurin, PTKs, PI 3-kinase,
PKC, and MAPK
Cell proliferation
Astrocytes FAK, p130Cas, RhoA Focal adhesion and
stress fiber formation
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increased activation of latent transforming growth factor
(TGF)-β, without significant differences in the early inflam-
matory response [14]. Ongoing phenotypic characterization of
the Thy-1 null mouse using this and other disease models will
likely elucidate additional roles for Thy-1 in vivo.
Thy-1 has been reported to function in T cell activation,
neurite outgrowth, apoptosis, tumor suppression, and wound
healing and fibrosis [20]. To mediate these diverse effects, Thy-
1 signals through multiple pathways. Thy-1 is involved in T cell
activation, and the role for Thy-1 in T cells is extensively
reviewed elsewhere [21–23]. Anti-Thy-1 antibody induces T
cell proliferation and IL-2 synthesis when co-stimulated by
dendritic cells [24]. To mediate T cell proliferation, Thy-1
signals via tyrosine kinases and MAPK [21,25]. Thy-1 can
signal via integrins, focal adhesion kinase (FAK), and Rho to
mediate cell adhesion [26,27]. Thy-1 can also activate cell death
and inhibit tumorigenic growth of cancer cells [28–35].
Expression of Thy-1 modulates the proliferative responses of
fibroblasts to cytokines and growth factors [36–40]. Lastly, like
other GPI-anchored molecules, Thy-1 localizes to lipid rafts
[23], and this localization appears critical for Thy-1 signaling.
2. Thy-1 and cellular adhesion signaling
The formation and disassembly of focal adhesion structures,
as well as other cell–cell and cell–matrix interactions, primarily
involve integrin-related signaling [41,42]. Thy-1–integrin
interactions are primarily involved in heterotypic interactions
between cells. Thy-1 expressed on neurons and endothelial cells
interacts with β2 and β3 integrins on astrocytes, leukocytes,
and melanoma cells [43–48] (Table 1). The interaction of
neuronal Thy-1 with integrin β3 on astrocytes induces
recruitment of FAK, paxillin, and vinculin to focal adhesions
(Table 2). FAK and p130Cas activation are increased,
stimulating focal adhesion formation and cell adhesion [27]
(Fig. 1A). The Thy-1-induced focal adhesion formation is
dependent on β3 clustering and RhoA activation [26]. Because
Thy-1 expression on neurons inhibits neurite outgrowth [49], it
has been suggested that the interaction between Thy-1 and β3
may activate bidirectional signaling inducing structural changesTable 1
Summary of Thy-1/integrin signaling
Cell type
expressing Thy-1
Integrin receptor Signaling
pathway
Effect
Endothelial cell αXβ2,
αMβ2 on
leukocytes
unknown Transendothelial cell
migration, potential
role in leukocyte
extravasation
Endothelial cell αvβ3 on
melanoma
cells
unknown Transendothelial cell
migration, potential
role in melanoma
metastasis
Neuron β3 on
astrocytes
FAK, p130Cas,
RhoA, vinculin
and paxillin
recruitment
Focal adhesion and
stress fiber formation
in astrocytesin β3-expressing astrocytes and potentially modulating neurite
outgrowth of Thy-1-expressing neurons [45]. The mechanism
and effects of bidirectional signaling between Thy-1 and β3 are
still not fully characterized but warrant further investigation, as
downregulation of Thy-1 expression or inhibition of Thy-1
signaling on mature neurons may facilitate nerve regeneration.
Endothelial cell Thy-1 interacts with αvβ3 on melanoma
cells and αXβ2 and αMβ2 on leukocytes [43,44,46–48]
(Table 1). These interactions promote melanoma cell and
leukocyte migration through an endothelial cell monolayer,
suggesting that Thy-1 signaling may be important for melanoma
metastasis and leukocyte recruitment and extravasation [44,46].
Whether Thy-1 interacts with integrins within the same cell is
unknown. It will be interesting to examine whether promotion
of transendothelial cell migration by Thy-1 observed in vitro
also occurs in vivo and to determine whether Thy-1 knockout
mice have abnormalities of leukocyte recruitment or are less
susceptible to melanoma metastases.
Adhesive signaling affects cell migration [50]. In the rat
brain, Thy-1 is expressed at highest concentrations in the
striatum and hippocampus [51]. Thy-1 is reported to function
in the brain by either inhibiting or promoting neurite
outgrowth [49,52]. Thy-1 expression on a neural cell line
inhibits neurite outgrowth over an astrocyte substrate, but not
over a substrate composed of Schwann cells or embryonic
glial cells [49]. As Thy-1 expression is upregulated on mature
neurons, and neurite outgrowth is necessary for neuronal
growth and synapse formation [3,7,53], Thy-1 may stabilize
neuronal synapses and inhibit neuronal regeneration of mature
neurons.
Thy-1-induced neurite outgrowth requires calcium influx,
activation of L- and N-type calcium channels, and G-protein
signaling [52]. In avian neurons, Thy-1 interacts with fyn, Gαi
family members, and α- and β-tubulin within lipid rafts (Table
2; Fig. 1B). Addition of an anti-Thy-1 antibody decreased the
overall kinase activity within the isolated lipid rafts [54], and
these changes in signaling may contribute to the effects of
Thy-1 on neurite outgrowth. Additionally, using primary rat
cerebellar neurons, Thy-1 was isolated from lipid rafts enriched
with prion protein, lyn, and fyn [55]. In fish retinal ganglion cell
Fig. 1. Schematic of Thy-1-associated signaling pathways. (A) Thy-1 interacts with both β2 and β3 integrins. The association of neuronal Thy-1 with β3 on astrocytes
induces activation of FAK, vinculin, paxillin, p130Cas, and RhoA, promoting focal adhesion and stress fiber formation. This interaction may induce bidirectional
signaling by concurrently signaling an inhibition of neurite outgrowth in mature neurons. Endothelial cell Thy-1 also interacts with β2 on leukocytes and β3 on
melanoma cells to promote transendothelial cell migration in vitro. (B) Thy-1 associates with protein tyrosine kinases such as SFK within lipid rafts. This interaction
may induce apoptosis of glomerular mesangial cells, promote neurite outgrowth in neurons, inhibit migration of pulmonary fibroblasts by altering the cytoskeleton,
and promote T cell activation. (C) Thy-1 activation induces apoptosis in thymocytes, glomerular mesangial cells, and mouse malignant T cells. In malignant T cells,
Thy-1 activation activates caspases and downregulates anti-apoptotic bcl-2 and bcl-XL. In an anti-Thy-1-induced model of glomerulonephritis, the apoptosis-related
genes NGFI-B and Gadd 45 γ are upregulated. In this same model, the expression of cell cycle regulatory proteins is also modulated (see text for details). (D) Thy-1
promotes proliferation of mesangial cells via activation of Smad1 and STAT3, and proliferation of T cells through a pathway involving calcineurin, protein tyrosine
kinases, PI-3 kinase, protein kinase C, and MAPK. Thy-1 also promotes TGF-β activation, cytokine/growth factor signaling, eicosanoid production, and
myofibroblasts/lipofibroblast differentiation. (E) Thy-1 functions as tumor suppressor in nasopharyngeal carcinoma and ovarian cancer cells, potentially due to its
upregulation of thrombospondin-1 and fibronectin. *indicates that Thy-1 cross-linking is necessary for effect.
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pitates with reggie-1 and reggie-2 in noncaveolar lipid rafts,
suggesting that Thy-1 may modulate axon regeneration [56,57].
Interestingly, Thy-1 knockout mice develop grossly normal
brains and spinal cords, and axon regeneration following spinal
cord injury was not detected [58], perhaps indicating species-
specific functions of Thy-1 in neural tissue. Further investiga-
tion will be necessary to elucidate the exact role for Thy-1 in
neuronal network formation.
The effects of Thy-1 expression on tyrosine kinase activity
relevant to cell morphology and cell migration have also beeninvestigated in fibroblasts. SFK activation differs in Thy-1 (+)
and (−) pulmonary fibroblasts. At baseline, SFK and p190
RhoGAP activities are increased in Thy-1 (−) fibroblasts,
resulting in inactive Rho. Thy-1 (+) pulmonary fibroblasts,
however, have decreased SFK and p190 RhoGAP activity and
active Rho [59] (Table 2; Fig. 1B). SFK signaling modulates
focal adhesion turnover, and Rho activation can promote focal
adhesion formation [60,61]. Consistent with the different
baseline levels of these kinases, Thy-1 (+) and (−) fibroblasts
differ in cytoskeletal morphology and migration. Thy-1 (−)
pulmonary fibroblasts are polygonal, and contain small
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Thy-1 (−) pulmonary fibroblasts are also more migratory at
baseline in a wound healing assay [59]. Thy-1 (+) pulmonary
fibroblasts are spindle-shaped, have long focal adhesions and
well-organized stress fibers, and are less migratory at baseline
[59]. Following treatment with the matricellular protein
thrombospondin-1, only Thy-1 (+) pulmonary fibroblasts
undergo focal adhesion disassembly. This differential response
to Thy-1 is due to selective activation of phosphatidylinositol 3-
kinase (PI 3-kinase) and SFK in only Thy-1 (+) cells [63] (Fig.
1B). Perhaps Thy-1 is important in regulating cell migration
signaling pathways activated in response to matricellular
proteins such as thrombospondin-1, which are present during
early wound healing following injury. Loss or absence of Thy-1
expression, such as in a fibrotic condition, leads to dysregulated
cell migration.
Because the GPI anchor of Thy-1 does not traverse the cell
membrane, it is unclear how Thy-1 activates cytoplasmic
tyrosine kinases. The GPI anchor of Thy-1 may directly interact
with palmitoylated and myristylated cysteines on these kinases.
Other GPI-anchored proteins, such as CD55 and CD59, also
interact with cytoplasmic tyrosine kinases, and site-directed
mutagenesis of palmitoylation sites on the SFK members lck
and fyn inhibits their interaction with these GPI-anchored
proteins [64]. Alternatively, Thy-1 may interact with cytoplas-
mic tyrosine kinases through an adapter protein. Co-activation
of Thy-1 and CD3 activates the lipid raft transmembrane
adapter protein linker for activation of T cells (LAT) [65] (Fig.
1B). Thy-1 also interacts with an 85–90 kDa transmembrane
phosphorylated protein that contains binding sites for SH2
domain-containing proteins, including fyn, csk, PI 3-kinase, ras
GTPase activating protein (GAP), vav, and lck [66]. Investiga-
tion of the mechanism by which Thy-1 activates these
intracellular signaling molecules will further our understanding
of the functions of Thy-1, as well as those of other GPI-
anchored proteins.
3. Thy-1 and apoptosis
Thy-1 signals cell death in malignant mouse T cells,
thymocytes and glomerular mesangial cells [31–34]. In vitro,
the addition of cross-linking anti-Thy-1 antibodies to rat
glomerular mesangial cells induces apoptosis, characterized
by TdT-mediated dUTP nick-end labeling (TUNEL) and
annexin V assays [32]. In vivo, injection of an anti-Thy-1
antibody into rats induces kidney mesangial cell death and
glomerulonephritis, suggesting Thy-1 may play a role in
glomerular function [34,67]. Aged Thy-1 deficient mice are
more susceptible to T cell lymphomas, suggesting that Thy-1
may function in negative selection possibly by regulating
apoptosis [68].
Cell death induced by the anti-Thy-1 antibody involves both
apoptotic proteins and cell cycle regulators. Following anti-
body-induced Thy-1 aggregation, caspases are activated and the
anti-apoptotic bcl-2 family members bcl-2 and bcl-XL are
downregulated in malignant mouse T cell lymphoma cells [33]
(Fig. 1C). The apoptosis-related genes nerve growth factorinduced protein I-B (NGFI-B) and DNA-damage-inducible
protein 45 gamma (Gadd 45 γ) are also upregulated in the anti-
Thy-1-induced glomerulonephritis model [69].
Thy-1 associates with Src family kinase (SFK) members fyn
and lyn in rat mesangial cells and fyn in T cells [70,71]. This
signaling may be necessary for Thy-1-induced apoptosis (Fig.
1B). Thy-1 induction of apoptosis in glomerular mesangial cells
requires inositol triphosphate production and protein tyrosine
kinase signaling, as well as an increase in intracellular calcium
[72].
Electron microscopy studies suggested that the mesangial
cell death induced by anti-Thy-1 antibodies may be necrotic
rather than apoptotic, as no chromatin condensation, nuclear
membrane disruption, cell swelling, or organelle degradation
were detected [73]. However, more recent studies have
determined that anti-Thy-1-induced nephritis is a combination
of complement-mediated necrosis and apoptosis [35]. As Thy-1
is also expressed on human mesangial cells [74], understanding
the role of Thy-1 in inducing mesangial cell death in mice may
have implications in the understanding of the pathogenesis and
treatment of renal diseases in humans. To date, changes in
expression of Thy-1 in human renal disease have not been
reported. Because loss of Thy-1 expression has been associated
with cancer and fibrosis, it will be interesting to determine
whether its effects on cellular apoptosis and survival are
important in these conditions.
4. Thy-1 and cell proliferation
Hematopoietic stem cells sorted based on Thy-1 expression
differ in cell cycle distribution. Following cytokine stimulation
for 6 days, Thy-1 (+) stem cells entered the cell cycle, whereas
Thy-1 (−) cells remained quiescent. Because proliferation of
gene-expressing cells is necessary for a therapeutic effect in
gene therapy, these differences may be useful in targeting stem
cells that are better suited for gene therapy [75]. Anti-Thy-1-
induced T cell proliferation requires signaling via calcinuerin,
protein tyrosine kinases, PI-3 kinase, protein kinase C, and
MAPK [25] (Table 2). Thy-1 (−) fibroblasts are more
proliferative in response to fibrogenic cytokines and growth
factors, as discussed below.
In the anti-Thy-1-induced nephritis model, as stated above,
mesangial cells undergo cell death by a mechanism combining
apoptosis and necrosis during the early phase [35], but then
secondarily proliferate via activation of Smad1 and STAT3
during the late phase [76] (Table 2; Fig. 1D). Treatment with
mycophenolate mofetil, an inhibitor of de novo guanosine
nucleotide synthesis, or roscovitine, a cyclin-dependent kinase
inhibitor, reduced mesangial cell proliferation by downregulat-
ing cyclin D expression and upregulating the cyclin inhibitor
p27kip1, suggesting these drugs may be useful in preventing
mesangial proliferative glomerulonephritis [77]. Antibody to
Thy-1 induces mesangial cell apoptosis or proliferation in a
time-dependent manner that appears to be due to activation of
different signaling pathways.
On the other hand, Thy-1 may inhibit proliferation and
thus function as a tumor suppressor in ovarian cancer and
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tumorigenic human ovarian cancer cell lines [30]. Addition
of Thy-1 antisense into a non-tumorigenic clone restored
tumorigenicity. Furthermore, SCID mice injected subcuta-
neously with ovarian cancer cells expressing Thy-1 formed
tumors that were smaller and propagated more slowly than
ovarian cancer cells not expressing Thy-1 [28]. Additionally,
Thy-1 may function as a tumor suppressor by up-regulating
fibronectin and the anti-angiogenic molecule thrombospondin-
1 [29] (Fig. 1E).
Epigenetic suppression of Thy-1 expression due to promoter
hypermethylation has been detected in many nasopharyngeal
cell carcinoma (NPC) cell lines, as well as in NPC tumor
samples. Colony formation of NPC HONE1 cells is decreased
following re-expression of Thy-1 [8]. Oncogenic transformation
of NIH 3T3 cells by ras oncoproteins, resulting in anchorage-
independent growth and soft agar colony formation, is
associated with loss of Thy-1 surface expression [78]. As
with proliferation, the role of Thy-1 in tumorigenesis is unclear.
Thy-1 facilitates melanoma cell migration through a transen-
dothelial cell monolayer [47], yet functions as a tumor
suppressor in ovarian cancer and NPC [8,28–30]. Differences
in the role of Thy-1 in cell proliferation may be cell type-
specific, and the effects of Thy-1 on tumorigenicity may be
mediated through non-proliferative mechanisms. It will be
interesting to examine whether Thy-1 knockout mice are more
susceptible to tumor invasion and metastasis.
5. Thy-1 and cytokine/growth factor signaling
Normal lung fibroblasts are heterogeneous, and the most
extensively characterized in vitro model of fibroblast hetero-
geneity is based on the cell surface expression of Thy-1
[37,62]. Fibroblasts sorted based on Thy-1 expression differ
in their response to and/or production of many cytokines and
growth factors (Table 3; Fig. 1D). Thy-1 (+) splenic fibro-
blasts secrete greater levels of interleukin (IL)-6 at baseline,Table 3
Summary of Thy-1 and cytokine/growth factor signaling in fibroblasts
Cytokine/growth factor
stimulation
Differential fibroblast response
At baseline Thy-1 (+) splenic fibroblasts secrete higher levels of
IL-6
At baseline Thy-1 (+) myometrial fibroblasts express COX-1 and
secrete high levels of PGE2, and Thy-1 (−) fibroblasts
express COX-2
TNFα Only Thy-1 (−) pulmonary fibroblasts secrete IL-1
and activate latent TGF-β
IL-1β Only Thy-1 (−) pulmonary fibroblasts have increased
IL-6 secretion, increased proliferation, and activation
of latent TGF-β
PDGF Only Thy-1 (−) pulmonary fibroblasts express PDGF-
α, undergo PDGF-AA-induced proliferation, and
activate latent TGF-β
Fibrogenic stimuli Thy-1 (−) pulmonary fibroblasts produce more TGF-
β, and only Thy-1 (−) pulmonary fibroblasts are able
to activate latent TGF-βbut only Thy-1 (−) pulmonary fibroblasts secrete IL-1 follow-
ing tumor necrosis factor (TNF)-α stimulation [36,79].
Following IL-1β stimulation, Thy-1 (−) pulmonary fibroblasts
have increased proliferation and IL-6 expression as compared
to Thy-1 (+) fibroblasts [38]. Interestingly, both subsets
express IL-1 receptor components and activate NFκB-1 in
response to IL-1β, suggesting that Thy-1 may affect non-
canonical IL-1 signaling pathways. Thy-1 (−) pulmonary
fibroblasts express higher levels of platelet-derived growth
factor (PDGF)-α and are selectively responsive to PDGF-AA-
induced proliferation [39]. Furthermore, PDGF stimulation of
human smooth muscle cells increases the levels of Thy-1
localized to lipid rafts [80].
Non-lung fibroblasts can also be divided into heterogeneous
populations based on the expression of Thy-1. Fibroblasts
isolated from the human female reproductive tract differ in
cyclooxygenase (COX) expression and prostaglandin (PG)
release. Thy-1 (+) myometrial fibroblasts express high levels of
COX-1 and produce high levels of PGE2, whereas Thy-1 (−)
fibroblasts constitutively express COX-2 and produce low
levels of PGE2 [81] (Fig. 1D).
The differing responses of Thy-1 (+) vs. (−) fibroblast
subpopulations to cytokines and growth factors suggest that
Thy-1 may affect fibroblast function during wound healing
and fibrosis. In response to fibrogenic stimuli, Thy-1 (−)
pulmonary fibroblasts produce more latent TGF-β than Thy-1
(+) fibroblasts and are selectively able to activate latent TGF-
β, suggesting Thy-1 expression may provide protection from
a fibrogenic response [82,83] (Fig. 1D). The role for Thy-1 in
fibrosis has been confirmed in vivo. Intratracheal bleomycin
administration induces pulmonary fibrosis in animal models
characterized by pulmonary parenchymal inflammation,
epithelial cell injury, interstitial and intra-alveolar fibrosis,
and formation of fibroblastic foci [84,85]. Following
intratracheal bleomycin, Thy-1 knockout mice develop more
severe pulmonary fibrosis than wild type mice. Fibrotic le-
sions from bleomycin-exposed wild-type mice contain mostly
Thy-1 (−) myofibroblasts with active TGF-β. Furthermore,
tissue sections from patients diagnosed with idiopathic
pulmonary fibrosis contain fibroblastic foci composed of
Thy-1 (−) myofibroblasts, whereas most normal human lung
fibroblasts are Thy-1 (+) [14].
Myofibroblasts are contractile fibroblasts expressing α-
smooth muscle actin (SMA), and these cells often persist in
fibrotic lesions [86,87]. It remains unclear how Thy-1
expression affects the ability of fibroblasts to differentiate
into myofibroblasts (Fig. 1D). In pulmonary fibrosis, lack of
Thy-1 expression seems to correlate with myofibroblast
differentiation in the mouse bleomycin model and in human
idiopathic pulmonary fibrosis [14]. Furthermore, Thy-1 (−)
pulmonary fibroblasts have higher α-SMA protein expression
at baseline and in response to TGF-β [83]. IL-1 and TNFα
treatment of pulmonary fibroblasts promotes a loss of Thy-1
expression and differentiation to a myofibroblast phenotype
[14]. However, the relationship of Thy-1 to the myofibro-
blasts phenotype appears to be tissue-dependent. Following
treatment with TGF-β or supernatant from platelets, only
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entiated into myofibroblasts expressing α-SMA. Thy-1 (−)
cells instead differentiated into lipofibroblasts [88]. The
observed differences may be a result of different roles for
Thy-1 in different tissues.
6. Thy-1 and lipid raft signaling
The GPI anchor of Thy-1 localizes the protein to specific
lipid raft microdomains. When the GPI anchor of Thy-1 was
replaced with sequences from the transmembrane domains of
neural cell adhesion molecule (NCAM) or of CD8, Thy-1-
mediated inhibition of neurite outgrowth was blocked. In cells
expressing a transmembrane domain in place of the GPI anchor,
Thy-1 was localized to different lipid raft microdomains than
was wild type Thy-1 [89]. Both wild type/GPI-anchored Thy-1
and transmembrane Thy-1 localized predominantly to filopodia,
but GPI-Thy-1 was excluded from coated pits [89]. Moreover,
Thy-1 localizes to a lipid raft microdomain distinct from that of
the GPI-anchored prion protein [90,91]. Lipid rafts containing
prion protein contained significantly higher levels of unsatu-
rated, longer chain lipids, whereas lipid rafts containing Thy-1
had 5-fold higher levels of hexosylceramide. The authors
suggest that the differences in localization of these two GPI-
anchored proteins reflect protein-specific trafficking and
solubility [90]. Furthermore, localization to specific domains
within lipid rafts may place Thy-1 in proximity to other
signaling molecules such as cytoplasmic tyrosine kinases. For
example, Thy-1 associates with reggie-1 and -2, prion protein,
and fyn and lyn within lipid rafts [55–57]. Crosslinking of prion
protein in Jurkat and human peripheral blood T cells induces
recruitment of Thy-1, TCR/CD3, fyn, lck, and LAT to reggie-
containing lipid rafts [92]. There is also evidence that Thy-1
signaling requires lipid raft integrity. Disruption of lipid rafts
blocks thrombospondin-1-induced focal adhesion disassembly
in Thy-1 (+) pulmonary fibroblasts [63]. Much work still needs
to be done in determining the role of Thy-1 in lipid raft
signaling. Thy-1 may signal and recruit other signaling
molecules via interaction with a transmembrane adapter protein
or via lipid interactions with palmitoylated and myristylated
cytoplasmic tyrosine kinases. Alternatively, Thy-1 may not
signal directly, but may function as a scaffolding or partitioning
protein within lipid rafts.
7. Concluding remarks
Thy-1 has diverse cellular functions and activates multiple
signaling pathways, affecting cell interactions with the
extracellular environment or with other cells, and influencing
cell proliferation, differentiation, and survival. Further
exploration of the role of Thy-1 signaling in these cell
processes in vitro and in animal models may advance our
understanding of nerve regeneration, glomerulonephritis,
tumorigenesis, wound healing and fibrosis in humans. Thy-
1 interacts with both integrins and cytoplasmic tyrosine
kinases to promote cell adhesion. Thy-1 appears to inhibit
cellular migration at baseline, but it may facilitate regulatedmigration in response to injury, via both tyrosine kinase- and
lipid raft-dependent mechanisms. The interaction with
cytoplasmic tyrosine kinases may also be required for Thy-
1-induced apoptosis, and potentially for the development of
glomerulonephritis. Thy-1 also affects proliferation of tumor
cells and fibroblasts, suggesting a role for Thy-1 in
tumorigenesis and fibrogenesis. It is important to reiterate
that the effects of Thy-1 are tissue- and cell type-specific.
Although Thy-1 signaling has been presented in this review
as activating multiple signaling pathways, it is possible that
Thy-1 signals through few pathways or a single pathway, and
that the other signaling cascades discussed in this article are
connected via cross-talk. For example, there is evidence that
Thy-1 signals via the MAPK pathway. Anti-Thy-1 induced T
cell proliferation requires MEK1 signaling, and MAPK
signaling was required for IL-1β-induced COX-2 expression
in Thy-1 (+) myometrial fibroblasts [25,81]. MAPK signaling is
involved in many of the processes that Thy-1 modulates,
including apoptosis, cell proliferation, focal adhesion disas-
sembly [93]. It will be necessary to further dissect signaling
molecules activated downstream of Thy-1 to determine if Thy-1
is indeed part of a single signaling pathway or multiple
pathways.
Although much work has been done in elucidating the role of
Thy-1 within signaling pathways, the exact mechanism(s) by
which Thy-1 signals remains unclear. Potentially, Thy-1 may
directly interact with signaling molecules such as SFK and
integrins. Additionally, Thy-1 may be part of a larger signaling
complex including transmembrane adapter proteins and cyto-
plasmic signaling molecules. Regardless of the mechanism(s),
there is an established role for Thy-1 in multiple cellular
processes with broad clinical significance.
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